0000000000269857
AUTHOR
E. Rubio-gomis
showing 3 related works from this author
Estudio de la relación entre adherencia a la Escuela de la Espalda y afrontamiento del dolor en pacientes con lumbalgia crónica
2019
Resumen Introduccion La Escuela de la Espalda (EE) es un tratamiento en pacientes con lumbalgia cronica con contenidos educativos asociados a otras medidas terapeuticas como ejercicios. Es eficaz si se realiza y es bien conocido que las modificaciones en los habitos diarios son dificiles de cumplir. Este trabajo de investigacion evalua si los pacientes que al terminar la EE tienen un predominio de estrategias activas en su afrontamiento del dolor se adhieren mejor a las ensenanzas de la EE. Material y metodo Estudio observacional prospectivo para valorar la adherencia a la EE en pacientes con dolor lumbar cronico. Se incluyeron pacientes adultos que aceptaban realizar la EE. Se excluyeron a…
Characteristics of histamine tachyphylaxis in rat uterine smooth muscle.
2002
Objective and design: To study both the desensitisation induced by short-term exposure to histamine and the mechanism responsible in the isolated rat uterus.¶Material: Precontracted isolated uterus (37 mM KCl) from oestrogenised Wistar rats were used.¶Treatment: Repetitive responses to histamine (10–6, 10–5, 10–4, 10–3 M), dimaprit and clonidine (10–4 M) were tested at 15, 30, 45 and 105 min., with their modifications by (5 mg/ kg, 24 h before sacrifice) reserpine, 10–7 M propranolol, 10–8 M atropine, and 10–6 M indomethacin. Dose-response curves for adrenaline were carried out as standard protocol.¶Methods: In vitro techniques (de Jalon's solution, 31°C, carbogen, isotonic registration, re…
Fluticasone in mild to moderate atopic dermatitis relapse: A randomized controlled trial
2018
Background: The long-term efficacy of corticosteroids to prevent atopic dermatitis (AD) relapses has partially been addressed in children. This study compared an intermittent dosing regimen of fluticasone propionate (FP) cream 0.05% with its vehicle base in reducing the risk of relapse in children with stabilized AD. Methods A randomized controlled, multicentric, double-blind trial was conducted. Children (2-10 years) with mild/moderate AD (exclusion criteria: > 30% affected body surface area and/or head) were enrolled into an Open-label Stabilization Phase (OSP) of up to 2 weeks on twice daily FP. Those who achieved treatment success entered the Double-blind Maintenance Phase (DMP). They w…